Navigation Links
Lo screening trial sul cancro al seno conclude che l'utilizzo della mammografia 3D in combinazione con un esame del seno 2D rileva un numero di tumori significativamente maggiore rispetto al solo esame del seno 2D
Date:1/17/2013

BEDFORD, Massachusetts, 17 gennaio 2013 /PRNewswire/ -- Hologic, Inc. (Hologic o la società) (NASDAQ: HOLX), leader nello sviluppo, nella produzione e nella fornitura di sistemi diagnostici e medici di acquisizione delle immagini e di prodotti chirurgici di alta qualità dedicati al servizio delle esigenze di salute delle donne, ha annunciato il 9 gennaio 2013 che un nuovo studio rivoluzionario, pubblicato su Radiology, la rivista scientifica della Radiological Society of North America, ha riscontrato che l'aggiunta all'esame 2D di screening al seno della tecnologia a tre dimensioni (3D) per la mammografia (tomosintesi al seno) di screening  aumenta in maniera significativa la rilevazione del cancro e riduce il numero di falsi positivi.

Lo studio, "Comparison of Digital Mammography Alone and Digital Mammography plus Tomosynthesis in a Population-based Screening Program" (Confronto della sola mammografia digitale con la mammografia digitale abbinata alla tomosintesi in un programma di screening sulla popolazione), è stato condotto da Per Skaane, M.D., Ph.D. dell'Ospedale Universitario Ullevaal di Oslo. Lo studio è stato basato su 12.631 esami di screening in un grande ospedale norvegese.

I ricercatori hanno riscontrato, mediante la tecnologia Hologic della mammografia 3D di in combinazione con una mammografia 2D, un notevole aumento nei tassi di rilevazione del cancro e una contemporanea diminuzione di falsi positivi rispetto alla sola mammografia 2D. Risultati importanti includono:

  • Un aumento del 40% nella rilevazione di cancri al seno invasivi
  • Un aumento del 27% nella rilevazione di tutti i cancri (invasivi e in situ)
  • Una riduzione del 15% nei falsi positivi

    • Gli autori hanno riferito che l'aumento nella rilevazione de
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related medicine technology :

    1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
    2. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
    3. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
    4. Trovagene Announces Plans to Develop Proprietary Test for High Risk HPV Carrier Screening from Urine
    5. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
    6. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
    7. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
    8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
    9. New Study Answers CMS/USPSTF Concerns for CT Colonography Screening Reimbursement: It is a Viable Option for the Medicare-Aged Population
    10. Pulse Oximetry Screening Hailed as the New Milestone to Combat Critical Congenital Heart Disease - Signal Extraction Technology Leading the Way in Large, Independent Clinical Studies
    11. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... DIEGO , May 23, 2013  MedVantx, Inc., ... consumer pharmaceutical distribution channel announced today the Company has ... to manage $1.5B in pharmaceutical products and the upgrade ... akin to cGMP facilities in its specialty home delivery ... The Company provides leading pharmaceutical manufacturers, physicians, health systems ...
    (Date:5/23/2013)... 2013   BioLife Solutions , Inc. (OTC:BLFS), a ... hypothermic storage and cryopreservation freeze ... media manufacturer , today announced its participation at the ... 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President and ...
    (Date:5/23/2013)... Mai 2013 Ranbaxy Laboratories ... von Daiichi Sankyo Co., Ltd. (im ... Mai die Maßnahmen bekannt, die Ranbaxy ... um sich der Angelegenheiten der vorhergehenden ... ). Daiichi Sankyo unterstützt ...
    Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
    ... C, LymphoStat-B(R) for lupus and ABthrax(R) for inhalation anthrax ... trial of darapladib underway in chronic coronary heart disease ... $25 million net cash burn -ROCKVILLE, Md., Jan. 12 ... ) will announce its priority goals for 2009 and ...
    ... InterMune, Inc.,(Nasdaq: ITMN ) today announced ... Monday, January 12 at 8:30 a.m. EST to discuss ... virus (HCV) protease inhibitor ITMN-191,(R7227) in combination with Pegasys(R) ... HCV genotype 1. ITMN-191 is,being developed in collaboration with ...
    Cached Medicine Technology:Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 2Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 3Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 4Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 5Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 6Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 7Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 8Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference 9InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191 2
    (Date:5/23/2013)... Sika Sarnafil , the worldwide market leader in ... Systems of Iowa as the Recycling Project of the ... the re-roofing of the SuperTarget retail store in Olathe, ... contractor and one of Target’s Preferred Tier One roofing ... building practices and they are a worthy recipient of ...
    (Date:5/23/2013)... Kentucky (PRWEB) May 23, 2013 Professional ... KY, encourages the nation to celebrate Fibromyalgia Education and ... provider for chiropractors across the country, the agency feels ... become aware of this syndrome that affects an estimated ... National Fibromyalgia Association , the definition of Fibromyalgia (FM) ...
    (Date:5/23/2013)... Vancouver, BC (PRWEB) May 23, 2013 ... the brown patches, but on skins of colour, this ... standard, only skin types 1-1V may be treated safely ... to pigmentation and skin discoloration issues, have been left ... have been unable to “clear” their skin successfully. , ...
    (Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... their cholesterol, but the medications also could hamper heart ... researchers say. A small group of overweight or ... gains while taking a 40 milligram daily dose of ... undergoing the same exercise regimen did show improvement, found ...
    (Date:5/23/2013)... soldier PTSD , Soldiers returning home from combat ... stress disorder if public support for a war effort ... invalidation shapes the level of distress soldiers feel from ... involved two experiments that asked participants to exterminate woodlice ... an actor show either interest or disgust for the ...
    Breaking Medicine News(10 mins):Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 2Health News:Vancouver Skin Care Clinic Successfully Clears Pigmentation in Skin of Colour 3Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3
    ... ... been appointed Division Director of Reproductive Endocrinology and Infertility (REI) services ... Hospital. Dr. Hurwitz is an infertility specialist in reproductive endocrinology ... with Reproductive Medicine Associates of Connecticut (RMACT) – NY & CT ...
    ... be key to treating anger among Iraq/Afghanistan Veterans, according to ... and Veterans Affairs researchers. "Most returning veterans don,t ... the small subset who do, this study helps to identify ... the study, an assistant professor of psychiatry in the UNC ...
    ... prevent 100,000 deaths worldwide each year, study suggests , ... commonly used to prevent excess bleeding in surgeries could ... trauma, a new study suggests. , The drug, tranexamic ... and easily administered, experts said. It works by significantly ...
    ... inconclusive evidence that diet, exercise, supplements prevent dementia , ... enough evidence to say that improving your lifestyle can ... , A group put together by the U.S. National ... if lifestyle, diet, medical factors or medications, socioeconomic status, ...
    ... nutrition staved off cataracts; some drugs, smoking increased vision ... -- A healthy diet helps guard against cataracts, while ... of vision loss, two new studies suggest. , And ... of age-related macular degeneration, another disease that robs people ...
    ... Ariz. June 14, 2010 Researchers at the ... Institute (VARI) and the Virginia G. Piper Cancer Center ... help in the treatment of patients with an aggressive ... researchers might better predict which patients with small cell ...
    Cached Medicine News:Health News:Infertility Specialist Dr. Joshua Hurwitz Appointed to Lead Division of Reproductive Endocrinology and Infertility at Danbury Hospital 2Health News:Infertility Specialist Dr. Joshua Hurwitz Appointed to Lead Division of Reproductive Endocrinology and Infertility at Danbury Hospital 3Health News:Study: Specific PTSD symptoms related to anger and aggressiveness among Iraq/Afghanistan veterans 2Health News:Drug That Stops Bleeding Could Save Lives 2Health News:Drug That Stops Bleeding Could Save Lives 3Health News:Lifestyle Changes Are No Guarantee Against Alzheimer's 2Health News:Lifestyle Changes Are No Guarantee Against Alzheimer's 3Health News:Diet, Meds and Smoking Linked to Eye Disease Risks 2Health News:Diet, Meds and Smoking Linked to Eye Disease Risks 3Health News:TGen-VARI-SHC research helps predict success with cancer drugs 2Health News:TGen-VARI-SHC research helps predict success with cancer drugs 3
    ... Monitors are designed exclusively for video endoscopy ... all Olympus endoscopy systems. When used in ... OEV-143 provides sharp, high-resolution images with excellent ... view - and details - necessary for ...
    ... It features over 600 TV lines of ... has four color temperature selections, scanning size selection ... control allows the user to easily set up ... settings for brightness, chroma, phase, contrast, volume and ...
    A comprehensive bioresorbable product line comprised of implants and accessories that serve craniomaxillofacial, neurosurgical, and iliac crest reconstruction....
    1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
    Medicine Products: